Evaxion Biotech A/S
Evaxion Biotech develops personalized and off-the-shelf cancer vaccines and prophylactic vaccines for infectious diseases using its AI-Immunology platform.
6-KSep 14Latest SEC filing, period to Sep 14
Jul 17Latest story
July 2026
Evaxion Biotech develops personalized and off-the-shelf cancer vaccines and prophylactic vaccines for infectious diseases using its AI-Immunology platform.